Oxytocin Market is expected to reach US$ 164.9 Million by 2030, with sales revenue expected to register 9.0% CAGR

The Oxytocin Market is anticipated to develop at a remarkable 9.0% CAGR from 2022 to 2030, reaching an estimated market value of over US$ 83.0 Million in 2022. By the end of 2030, the Oxytocin market is anticipated to reach US$ 164.9 Million. According to Future Market Insights’ predictions, Postpartum type will command a sizeable proportion of the global market in 2021, amounting to about 88.8%.

Future Market Insights (FMI), an ESOMAR-certified consulting organisation, recently released a thorough yet balanced research on the worldwide oxytocin market that identifies the key factors driving development over the long term. According to the report, demand for oxytocin would increase by approximately 8% globally through 2030 due to an increasing emphasis on PPH prevention.

Births are happening more frequently, but there are also more challenges for women to deal with. Over 50,000 women are thought to experience life-threatening problems nationwide, according to the Centres for Disease Control and Prevention.

Request a sample @
https://www.futuremarketinsights.com/reports/sample/rep-gb-11218

Consequently, healthcare providers are incorporating solutions aimed at reducing trauma faced by patients which include numerous approaches. A common complication faced by women is postpartum hemorrhage, for which oxytocin treatment is a highly preferred option. A value CAGR exceeding 8% is projected for the market through 2030.

Key Takeaways

• Postpartum hemorrhage (PPH) solutions to comprise nearly 90% of the revenue share in 2020 by product type
• Hospital pharmacies remain key distribution channels, online pharmacies’ popularity to widen
• Opportunities abound across the Middle East & Africa (MEA) owing to rising PPH incidence in Africa
• Global oxytocin market is projected to reach US$ nearly US$ 165 Mn by 2030

“Government initiatives to promote women and children’s health are bolstering global efforts to improve maternity care across healthcare settings, thereby opening significant growth avenues for the global oxytocin market,” comments the FMI analyst.

Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-11218

Therefore, efforts are being made towards ensuring adequate and proper treatment to pregnant women across all regions. Furthermore, oxytocin has also been touted as an effective anti-viral agent, thus raising optimism that it could be effectively leveraged to promote drug or vaccine development.

The National Center for Biotechnology Information hypothesizes that oxytocin contains dipeptidyl peptidase-4 (DPP4) protease inhibitors could be effective against the existing novel coronavirus strain. It further propagates that enhancing endogenous oxytocin levels could increase viral resistance and improve health of vulnerable groups.

Competitive Landscape:

Prominent players in the global oxytocin market include Pfizer Inc., Novartis AG, Ferring B.V., Fresenius Kabi LLC, Hikma Pharmaceuticals PLC, Endo International Plc. (Par Sterile Products, LLC), Teva Pharmaceuticals Ltd., Mylan N.V., Wockhardt Ltd., Sun Pharmaceutical Industries Ltd. and Yuhan Corporation.

The market is highly fragmented, peppered with numerous regional and global level market players. These players largely concentrate on forging strategic collaborations with existing players, regional distributors, product launches and acquisitions. Most players are concentrating on offering anesthetic oxytocin solutions to reduce labor induced complications for C-section operations.

Key Market Segments Covered in Oxytocin Industry Research

By Product:

• Antepartum
• Postpartum

Contact Sales for Further Assistance in Purchasing this Report @ https://www.futuremarketinsights.com/checkout/11218

By Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Drug Stores
• Online Pharmacies

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs